Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: A comparison with tyrosine kinase and protein kinase C inhibition

Biochemical Pharmacology

Volumn 53, Issue 11, 1997, Pages 1649-1657

  Agullo, Georgine ^a   Gamet Payrastre, Laurence ^a   Manenti, Stéphane ^b   Viala, Cécile ^b   Rémésy, Christian ^a   Chap, Hugues ^b   Payrastre, Bernard ^b  

^a CEMAGREF   (France)

^b CHU PURPAN   (France)

Author keywords

EGF receptor tyrosine kinase; Flavonoids; Myricetin; PI 3 kinase ; Protein kinase C; Structure activity study

Indexed keywords

APIGENIN; CATECHIN; DIACYLGLYCEROL KINASE; DIOSMETIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FISETIN; FLAVONOID; GENISTEIN; HESPERETIN; HYDROXYL GROUP; KAEMPFEROL; LUTEOLIN; MYRICETIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL KINASE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; QUERCETIN; TAXIFOLIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTORADIOGRAPHY; CELL TRANSFORMATION; CONTROLLED STUDY; DENSITOMETRY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LISTERIA MONOCYTOGENES; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

EID: 0030842112     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)82453-7     Document Type: Article

References (38)

1. Middleton E Jr and Kandaswami C, The impact of plant flavonoids on mammalian biology: Implications for immunity, inflammation and cancer. In: The Flavonoids: Advances in Research Since 1986 (Eds. Harborne JH and Liss AR), pp. 619-652. New York, 1993.
2. Geahlen RL, Koonchanok MN and McLaughlin JL, Inhibition of protein kinase C activity by flavonoids and related compounds. J Nat Products 52: 982-986, 1989.
3. Cushman M, Nagarathman D, Burg DL and Geahlen RL, Synthesis and protein-tyrosine kinase inhibitory activities of flavonoid analogues. J Med Chem 34: 798-806, 1991.
4. Ferriola PC, Cody V and Middleton E, Protein kinase C inhibition by plants flavonoids. Kinetic mechanisms and structure-activity relationships. Biochem Pharmacol 38: 1617-1624, 1989.
5. Kapeller R and Cantley LC, Phosphatidylinositol 3-kinase. BioEssays 16: 565-576, 1994.
6. Stoyanov B, Volinia S, Hack T, Rubio I, Loubchenkov M, Malek O, Stroyanova S, Vanhaesebroeck B, Dhand R, Nürnberg B, Gierschik P, Seedorf K, Hsvan JJ, Waterfield MD, Wetzker R, Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase. Science 269: 690-693, 1995.
7. Varticovski L, Harrison-Findik D, Keeler ML, Susa M, Role of PI 3-kinase in mitogenesis. Biochem Biophys Acta 1226: 1-11, 1994.
8. Cantley LC, Auger KR, Carpenter C, Duckworth, Graziani A, Kapeller R and Soltoff S, Oncogenes and signal transduction. Cell 64: 281-302, 1991.
9. Skorski T, Kanakaraj P, Nieborowska-Skorska M, Ratajczak MZ, Wen SC, Zon G, Gewirtz AM, Perussia B, and Calabretta B, Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells. Blood 86: 726-736, 1995.
10. Nakanishi S, Catt KJ and Balla T, A wortmannin-sensitive phosphatidylinositol 4-kinase that regulates hormones-sensitive pools of inositolphospholipids. Proc Natl Acad Sci USA 92: 5317-5321, 1995.
11. Matter WF, Brown RF and Vlahos CJ, The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs. Biochem Biophys Res Commun 186: 624-631, 1992.
12. Nishioka H, Imoto M, Sawa T, Hamada M, Naganawa H, Takeuchi T, Umezawa K, Screening phosphatidyl-inositol kinase inhibitors from streptomyces. J Antibiotics XLII: 823-825, 1988.
13. Singhal RL, Yeh A, Prajda N, Olah E, Sledge GW and Weber G, Quercetin down-regulates signal transduction in human breast carcinoma cells. Biochem Biophys Res Commun 208: 425-431, 1995.
14. Vlahos CJ, Matter WF, Hui KY and Brown RF, A specific inhibitor of phosphatidyl inositol 3-kinase, 2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269: 5241-5248, 1994.
15. Payrastre B, Gironcel D, Plantavid M, Mauco G, Breton M and Chap H, Phosphoinositide 3-phosphatase segregates from phosphatidylinositol 3-kinase in EGF-stimulated A431 cells and fails to in vitro hydrolyse phosphatidylinositol (3,4,5) trisphosphate. FEBS Lett 341: 113-118, 1994.
16. Guinebault C, Payrastre B, Racaud-Sultan C, Mazarguil H, Breton M, Mauco G, Plantavid M and Chap H, Integrin-dependent translocation of phosphoinositide 3-kinase to the cytoskeleton of thrombin-activated platelets involves specific interactions of P85α with actin filaments and focal adhesion kinase. J Cell Biol 129: 831-842, 1995.
17. c-src, phospholipase C, inositol-lipid, and diacylglycerol kinases with the cytoskeletons of thrombin-stimulated platelets. J Biol Chem 266: 15705-15709, 1991.
18. Manenti S, Sorokine O, Van Dorsselaer A and Taniguchi H, Affinity purification and characterisation of myristoylated alanine-rich protein kinase C substrate (MARKS) from bovine brain. J Biol Chem 267: 22310-22315, 1992.
19. Laemmli UK, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
20. Diakonova M, Payrastre B, van Velzen AG, Hage WJ, van Bergenuen Henegouwen P, Boonstra J, Cremers FFM and Humbel B, Epidermal growth factor induces rapid and transient association of phospholipase C-γ1 with EGF-receptor and filamentous actin at membrane ruffles of A431 cells. J Cell Sci 108: 2499-2509, 1995.
21. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itho N, Masabumi S and Fukami Y, Genistein, a specific inhibitor of tyrosine-specific protein kinase. J Biol Chem 262: 5592-5595, 1987.
22. Suolinna EM, Buchsbaum RN and Racker E, The effect of flavonoids on aerobic glycolysis and growth of tumor cells. Cancer Res 35: 1865-1872, 1975.
23. Post JFM, Varna RS, Growth inhibitory effects of bioflavonoids and related compounds on human leukemic CEM-C1 and CEM-C7 cells. Cancer Lett 67: 207-213, 1992.
24. Yoshida M, Sakai T, Hosokawa N, Marui N, Matsumoto K, Fujioka A, Nishino H and Aoike A, The effect of quercetin on cell cycle progression and growth of human gastric cancer cells. FEBS Lett 260: 10-13, 1990.
25. Hosokawa N, Hosokawa Y, Sakai T, Yoshida M, Marui N, Nishino H, Kawai K, Inhibitory effect of quercetin on the synthesis on a possible cell-cycle-related 17-kDa protein, in human colon cancer cells. Int J Cancer 45: 1119-1124, 1990.
26. Ranelletti FO, Ricci R, Larocca LM, Maggiano N, Capelli A, Scambia G, Benedetti-Panici P, Mancuso S, Rumi C, Piantelli M, Growth-inhibitory effect of quercetin and presence of type-II estrogen-binding sites in human colon-cancer cell lines and primary colorectal tumors. Int J Cancer 50: 486-492, 1992.
27. Matsukawa Y, Marui N, Sakai T, Satomi Y, Yoshida M, Matsumoto K, Nishino H, Aoike A, Genistein arrests cell cycle progression at G2-M. Cancer Res 53: 1328-1331, 1993.
28. Kandaswami C, Perkins E, Drzewiecki G, Soloiuk DS, Middleton E, Jr, Differential inhibition of proliferation of human squamous cell carcinoma, gliosarcoma and embryonic fibroblast-like lung cells in culture by plant flavonoids. Anti-cancer Drugs 3: 525-530, 1992.
29. Katagiri K, Katagiri T, Kajiyama K, Uehara Y, Yamamoto T, Yoshida T, Modulation of monocytic differentiation of HL 60 cells by inhibitors of protein tyrosine kinase. Cell Immunol 140: 282-294, 1992.
30. End DW, Look RA, Shaffer NL, Balles EA and Persico FJ, Non-selective inhibition of mammalian protein kinases by flavonoids in vitro. Res Commun Chem Pathol Pharmacol 56: 75-86, 1987.
31. Levy J, Teuerstein I, Marbach M, Radian S and Sharoni Y, Tyrosine protein kinase activity in the DMBA-induced rat mammary tumor: Inhibition by quercetin. Biochem Biophys Res Commun 123: 1227-1233, 1984.
32. Geschwendt M, Horn F, Kittstein W and Marks F, Inhibition of the calcium-and phospholipid-dependent protein kinase activity from mouse brain cytosol by quercetin. Biochem Biophys Res Commun 117: 444-447, 1983.
33. Chang CJ and Geahlen RL, Protein-tyrosine kinase inhibition: Mechanism-based discovery of antitumor agents. J Nat Products 55: 1529-1560, 1992.
34. Ireton K, Payrastre B, Chap H, Ogawa W, Sakaue H, Kasuga M, and Cossart P, A role for PI 3-kinase in bacterial invasion. Science 274: 780-782, 1996.
35. Hagiwara M, Inoue S, Tanaka T, Nunoki K, Ito M and Hidaka H, Differential effects of flavonoids as inhibitors of tyrosine protein kinases and serine/threonine proteine kinases. Biochem Pharmacol 37: 2987-2992, 1988.
36. Markovits J, Linassier C, Fosse P, Couprie J, Pierre J, Jacquemin-Sablon A, Saucier JM, Le Peck JB and Larsen AK, Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res 49: 5111-5117, 1989.
37. 1 phase of the cell cycle. Cancer Res 52: 6676-6681, 1992.
38. Hertog MGL, Kromhout D, Aravanis C, Blackburn H, Buzina R, Fidanza F, Giampaoli S, Jansen A, Menotti A, Nedeljkovic S, Pekkarinen M, Simic BS, Toshima H, Fesken EJM, Hollman PCH, Katan M, Flavonoid intake and long term risk of coronary heart disease and cancer in the Seven Countries study. Arch Intern Med 155: 381-386, 1995.